AbbVie ABBV Juvederm Collection — Net revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's juvederm collection — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's juvederm collection — net revenues?
- AbbVie (ABBV) reported juvederm collection — net revenues of $232M in Q1 2026.
- How has AbbVie's juvederm collection — net revenues changed year-over-year?
- AbbVie's juvederm collection — net revenues increased by 0.4% year-over-year, from $231M to $232M.
- What is the long-term trend for AbbVie's juvederm collection — net revenues?
- Over 4 years (2021 to 2025), AbbVie's juvederm collection — net revenues has grown at a -10.3% compound annual growth rate (CAGR), from $1.54B to $993M.
- What does juvederm collection — net revenues mean?
- This metric represents the total gross sales of the Juvederm product line minus returns, allowances, and discounts. It serves as a key indicator of market demand and competitive positioning within the medical aesthetics and dermal filler market. Tracking this revenue stream helps investors evaluate the performance of the company's non-therapeutic, consumer-facing portfolio.